Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy’s Laboratories Buys U.K. Dow Chemical Drug Units

This article was originally published in The Pink Sheet Daily

Executive Summary

Move bolsters India firm’s contract research capabilities.

You may also be interested in...



Dr Reddy’s Earnings Plunge On German Unit Charge, Increased Generic Competition

Indian generics marketer experienced price erosion in the U.S. in the third quarter.

Generic Giant: Dr. Reddy’s Acquires Betapharm Group

With the $576 mil. acquisition of Betapharm, Dr. Reddy’s will expand its presence in Europe.

List Ahead For Southeast Asia Pharma In 2015

PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.

Topics

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel